Klinika Oczna

Diagnostic and therapeutic challenges in a young adult with multifocal orbital tumours involving the optic nerve

  1. Students’ Scientific Society, Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia,
    Katowice, Poland

  2. Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland

  3. Department of Adult Ophthalmology, Prof. Kornel Gibiński University Clinical Centre, Medical University of Silesia, Katowice, Poland

KLINIKA OCZNA 2026, 128, 4: 1-5

Data publikacji online: 2026/11/16
Article file
KO-00596.pdf


Introduction

The orbit is an anatomically complex cone-shaped region with an apex limited by the superior orbital fissure and optic canal [1]. It contains the eyeball, extraocular muscles, fat, glands, nerves, veins, and arteries, together with surrounding bones, forming a highly intricate structure. Its proximity to the skull base makes it a technically demanding and high-risk area for surgery [2].

Orbital tumours may originate from any orbital tissue and can be primary, secondary, or metastatic. Aetiology depends on age, tissue origin, genetic predisposition, and environmental exposures [3]. They are rare, with an estimated incidence of 6–10 cases per million individuals. Epidemiological studies from the United States and South Korea indicate an increasing incidence of malignant orbital tumours [4, 5].

In adults, lymphoma is the most common primary malignant tumour, whereas benign lesions predominate in chil-
dren [6]. Approximately 60% of adult orbital tumours are benign and 40% malignant [4]. Risk factors include older age, immunosuppression, and ultraviolet radiation. Surgical removal may be required depending on symptoms, tumour growth, or suspicion of malignancy. Risk of complications rises with difficult locations such as the orbital apex, medial canthus, and advanced stages [7].

In this paper, we present the case of a 23-year-old patient with progressive visual deterioration in the left eye (OS) and orbital lesions detected on computed tomography (CT).
Diagnostic tests revealed impaired conduction in the left optic nerve. The patient had a history of left orbital cavernous haemangioma treated 15 years earlier. CT showed two orbital lesions, one of which was adjacent to the optic nerve, suggesting a venolymphatic malformation or nerve sheath tumour. This report highlights the diagnostic and therapeutic challenges of rare orbital lesions in young patients, particularly those involving the optic nerve.

Case report

A 23-year-old patient was admitted to the Department of Ophthalmology with a two-month history of progressive visual acuity deterioration in the OS and orbital lesions detected on CT. Apart from ophthalmic symptoms, the patient had no significant comorbidities. Medical history revealed a cavernous haemangioma of the left orbit diagnosed 15 years earlier and treated with two courses of methylprednisolone.

On admission, best-corrected visual acuity in the OS was 0.3, while in the right eye (OD) it was normal, and intraocular pressure was 15 mmHg in both eyes. Head CT revealed, within the left orbit adjacent to the posterior contour of the globe, a non-contrast-enhancing structure with the density of dense fluid measuring 10 × 17 mm. A second focal lesion measuring 14 × 10 mm was located extraconally at the orbital apex, adjacent to the optic nerve, and demonstrated contrast enhancement. These findings suggested a cystic–solid lesion with slow growth dynamics. The lesion protruded approximately 3 mm into the optic canal and superior orbital fissure, causing their widening without evidence of bone destruction.
The left optic nerve was thickened in the retrobulbar segment and showed contrast enhancement; at the orbital apex, it coursed through the described structure in a manner that prevented clear delineation on CT imaging. The first focal lesion was considered consistent with an orbital cavernous haemangioma, whereas the differential diagnosis of the second lesion included a venolymphatic malformation and a tumour arising from the optic nerve sheaths. Intravenous iodinated contrast medium was used for the CT examination. On dynamic post-contrast imaging, cavernous venous malformations (CVMs) characteristically show a slow, patchy-to-progressive centripetal filling pattern, distinct from the earlier, more homogeneous enhancement typical of nerve sheath tumours, which supported the radiological differential diagnosis in this patient (Figure 1).

Flash visual evoked potentials demonstrated normal latencies in both eyes but with amplitude in the OS reduced to 50%. Fluorescein angiography revealed two punctate areas of hyperfluorescence in the macular region of the OS without leakage from the optic disc. The peripheral retina was unremarkable, and the optic disc showed no contrast leakage;
the OD was normal. Flash electroretinography in the OS under scotopic conditions following 0.01 stimulation showed a reduced b-wave amplitude compared to the OD. After 3.0 stimulation both a- and b-wave amplitudes were reduced by more than 25%, while after 10.0 stimulation they were slightly
reduced. Oscillatory potentials and photopic wave amplitudes were similar in both eyes. The retina of the OS exhibited features consistent with mild ischaemia (Figure 2).

Static perimetry of the OS (Figure 3) (Humphrey Field Analyzer, Carl Zeiss Meditec, Inc.) revealed extensive, deep visual field defects. A markedly reduced Visual Field Index (VFI) of 17%, severe deterioration of mean deviation (−27.82 dB; p < 0.5%), and increased pattern standard deviation (8.60 dB; p < 0.5%) indicated severe optic nerve dysfunction. The glaucoma hemifield test was outside normal limits.

Ganglion cell complex (GCC) (Figure 4) analysis demonstrated normal GCC thickness in both eyes, with a slight deficit in the superior sector of the OS.

Chest radiography and laboratory tests were within normal limits. Infectious causes were excluded. Due to progressive visual deterioration and the orbital location of the lesions, the patient was referred to the Department of Neurosurgery for further evaluation. The neurosurgical consultation considered two principal treatment strategies, chosen according to lesion location and relationship to the optic nerve: endoscopic transnasal/transorbital orbitotomy approach or, if complete resection was judged too hazardous given the apical, perioptic location, endovascular or percutaneous occlusion of the lesion, either transarterial embolisation with agents such as n-butyl cyanoacrylate or detachable coils or direct intralesional sclerotherapy.

Topical treatment with brinzolamide twice daily and pranoprofen three times daily was initiated, along with systemic cefuroxime therapy.

Discussion

Orbital lesions are challenging due to the complex anatomy of the region and varied pathologies. In young patients, benign lesions like cavernous haemangiomas are common, whereas malignant tumours are rare [2, 4]. Imaging is essential for lesion detection, localisation, and assessment [8].

Beyond CT and magnetic resonance imaging, ocular ultrasonography complements the diagnostic work-up. On B-scan,
CVMs typically appear as well-circumscribed, compressible, hyperechoic masses, and colour Doppler imaging characteristically demonstrates low-flow signal within the vascular spaces. This helps distinguish them from higher-flow or infiltrative orbital vascular anomalies and from non-vascular tumours [9].

The most common orbital lesion in adults is orbital CVM, while lymphoma is the predominant malignant tumour in this age group. Calandriello et al. [9] describe cavernous haemangioma as typically a single, unilateral lesion, more often occurring in the left orbit, although multiple and bilateral cases have been reported. It more frequently affects women, usually in the fourth or fifth decade of life. CVM may coexist with other vascular anomalies or systemic syndromes such as Maffucci syndrome. They typically present as well-defined intraconal masses, often in the middle third of the orbit [8, 9],
causing gradual axial proptosis and visual disturbances in approximately 50% of patients. Optic neuropathy may lead to disc oedema and subsequent optic nerve atrophy [10].

In our patient, one lesion in the left orbit, adjacent to
the posterior contour of the globe, measured 10 × 17 mm, with fluid-like density without contrast enhancement. A second lesion located extraconally at the apex of the left orbit and adjacent to the optic nerve measured 14 × 10 mm and enhanced with contrast. Unlike the typical solitary, intraconal presentation, this patient had two distinct lesions, one showing cystic-solid characteristics, highlighting diagnostic complexity. The patient was a 23-year-old male, which deviates from the usual CVM profile seen in women in their fourth or fifth decade. The lesions were consistent with typical intraconal location but demonstrated atypical multiplicity and morphology. Additionally, the patient exhibited progressive visual acuity impairment. Histologically,
CVM consists of large, endothelial-lined vascular spaces separated by fibrous septa and surrounded by a fibrous capsule. They lack significant arterial supply, and slow blood flow predisposes to intralesional thrombosis. Cavernous haemangiomas are classified as low-flow, non-distensible venous malformations. The female predominance suggests a hormonal influence, with postmenopausal lesions typically remaining stable or decreasing in size [9–11].

Surgical treatment of CVM is indicated for optic nerve compression, visual disturbances, or significant proptosis.
Asymptomatic lesions are generally observed due to slow progression and rare acute complications. The surgical approach depends on lesion location and its relationship to critical neurovascular structures and may include anterior, lateral, or transcranial orbitotomy, as well as endoscopic approaches. Stereotactic radiosurgery can be considered for patients not eligible for surgery [9, 10].

Strianese et al. [12] evaluated 164 patients undergoing surgical excision of orbital CVM, reporting significant improvements in visual acuity, visual field, diplopia, proptosis, and ocular motility. Vision loss was rare (1.2%), and tonic pupil occurred in 3% of patients, more frequently in lateral lesions or apex involvement. Agosti et al. [13] performed a systematic review including 94 studies with 1007 patients. Complete resection was achieved in 93.7% of cases, with low complication rates (visual deterioration 3.9%, diplopia 2.4%, enophthalmos 1.7%). Endoscopic transnasal approaches provided high resection efficacy with minimal morbidity, while transorbital endoscopic approaches were promising for lateral lesions. Functional outcomes – particularly visual acuity and proptosis – improved. Sclerotherapy, including intralesional injection of pingyangmycin, is minimally invasive and useful for lesions that are difficult to excise, reducing lesion volume, proptosis, swelling, and pain [9]. In our patient, worsening visual acuity and lesion location prompted neurosurgical consultation.

Nerve sheath tumours may be benign or malignant, with schwannomas and neurofibromas being the most common benign lesions. Schwannomas typically appear as well-defined intramuscular masses, while neurofibromas are larger, infiltrative, and may involve bone [14].

Conclusions

A comprehensive diagnostic workup and appropriate therapeutic strategies can significantly improve the prognosis. The outcome depends on the extent of the lesion, histopathological diagnosis, anatomical location, and presence of distant metastases. Management of orbital tumours requires a multi-
disciplinary approach and close collaboration among ophthalmology, pathology, and neurosurgery specialists.

DISCLOSURES

The authors declare no conflict of interest.

This research received no external funding.

Approval of the Bioethics Committee was not required.

References


  1. Bleier BS, Castelnuovo P, Battaglia P, et al. Endoscopic endonasal orbital cavernous hemangioma resection: global experience in techniques and outcomes. Int Forum Allergy Rhinol 2016; 6: 156-161.
  2. Lieber S, Fernandez-Miranda JC. Anatomy of the orbit. J Neurol Surg B Skull Base 2020; 81: 319-332.
  3. Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patients during a 21-year period: origins and locations. Jpn J Ophthalmol 2005; 49: 49-55.
  4. Kisser U, Heichel J, Glien A. Rare diseases of the orbit. Laryngorhinootologie 2021; 100(Suppl 1): S1-S79. DOI: 10.1055/a-1384-4641.
  5. Zhang W, Rokohl AC, Guo Y, et al. Global incidence and prevalence of malignant orbital tumors. Adv Ophthalmol Pract Res 2024; 4: 128-133.
  6. Patel BCK. Malignant orbital tumors. In: Perry J, Singh A (eds.). Clinical ophthalmic oncology. Springer, Berlin, Heidelberg 2014; 141-154. DOI: 10.1007/978-3-642-40492-4_13.
  7. Gąsiorowski K, Gontarz M, Marecik T, et al. Risk factors for orbital invasion in malignant eyelid tumors, is orbital exenteration still necessary? J Clin Med 2024; 13: 726. DOI: 10.3390/jcm13030726.
  8. Khan SN, Sepahdari AR. Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies. Saudi J Ophthalmol 2012; 26: 373-383.
  9. Calandriello L, Grimaldi G, Petrone G, et al. Cavernous venous malformation (cavernous hemangioma) of the orbit: current concepts and a review of the literature. Surv Ophthalmol 2017; 62: 393-403.
  10. Low CM, Stokken JK. Typical orbital pathologies: hemangioma. J Neurol Surg B Skull Base 2021; 82: 020-026.
  11. Ayoub E, Farid A, Yahya C, et al. Cavernous hemangioma of the orbit: case report and a review of the literature. Radiol Case Rep 2022; 17: 4104-4107.
  12. Strianese D, Bonavolontà G, Iuliano A, et al. Risks and benefits of surgical excision of orbital cavernous venous malformations (so-called cavernous hemangioma): factors influencing the outcome. Ophthalmic Plast Reconstr Surg 2021; 37: 248-254.
  13. Agosti E, Ricciuti V, Mantovani G, et al. Surgical management and postoperative outcomes of orbital cavernous malformations: a systematic literature review by the EANS skull base section. Brain Spine 2025; 5: 104302. DOI: 10.1016/j.bas.2025.104302.
  14. Sweeney AR, Gupta D, Keene CD, et al. Orbital peripheral nerve sheath tumors. Surv Ophthalmol 2017; 62: 43-57.
Share
without publication fees
without publication fees